Cyclopharm Ltd has released a press release.
Cyclopharm: Trading Update & Record Technegas Order Received from China
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cyclopharm
- Cyclopharm to Proceed Independently with FDA Trials
- Cyclopharm Files Claim Against ANSTO
- Trading Update
- Renounceable Rights Issue and Sale of Unmarketable Parcels
- Renewal of Debt Facility with National Australia Bank
Later from Cyclopharm
- CYC Signs Agreement with the Canadian Association of Nuc Med
- Appendix 4D and Half Year Accounts
- Cyclopharm Business Update on Significant Milestones
- CYC Achieves USFDA Agreement For Technegas Trial Design
- CYC 2016 preliminary headline update-record results
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm